NCT05490901
The Prognostic Role and Diagnostic Efficacy of Exercise Right Heart Catheterization With a Simultaneous Echocardiography in Patients With Dyspnea on Exertion
Recruiting · Not specified · Samsung Medical Center · registry updated 2022-08-08
Inclusion and exclusion lines below are quoted from ClinicalTrials.gov. No match score is shown, because a score needs a person's age, biomarkers, and treatment dates. Confirm the record with the study team.
To evaluate the role of exercise hemodynamic testing in the diagnostic workup for patients with dyspnea on exertion referred to the catheterization lab.
Inclusion
- Subject must be at least 19 years of age.
- Patients with dyspnea on exertion
- Written informed consent of participating subjects after being fully briefed (for prospective analysis)
Exclusion
- Patients with incomplete hemodynamic data at rest or exercise
- Advanced tumor disease or other diseases with a short life expectancy
- Uncontrolled systemic arterial hypertension ( \> 160/100 mmHg at rest)
- FEV1\<50% predicted
- TLC\<60% predicted